Skip to content

Automated Tele Counseling for Screening Mammography

Automated Tele Counseling for Screening Mammography

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00247013
Enrollment
2120
Registered
2005-11-01
Start date
1996-01-31
Completion date
2006-01-31
Last updated
2016-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

automated telephone system, breast cancer, cancer prevention, intervention, mammography, screening

Brief summary

The purpose and aim of this study is to test the use of a computer-based, automated telecommunications system and its effectiveness in increasing the rates of regular screening mammography among women ages 50-74. The system will not only help in scheduling appointments but will help women in overcoming any barriers that may deter them from having the procedure at all. The programs are designed to be user friendly and easy to implement in clinical practice.

Detailed description

The primary goal of this project is to evaluate the effectiveness and acceptability of a computer-based telecommunications system for increasing rates of regular screening mammography among women ages 50-74. The Telephone-Linked-Communications for Mammography Screening (TLC-M) is designed to educate, advise and motivate women to have regular screening mammograms. There will be two versions of TLC-M: one for women who are coming due for their annual screening mammography (pre-due women) and one for women who have missed their annual mammogram (past-due women). TLC-M uses a real human voice to speak to the women on the telephone; the subjects communicate by using the touch tone keypad on their telephones. The intervention will consist of up to three automated telephone conversations. During the call TLC-M assesses the woman's willingness to have a mammogram, helps interested women schedule a mammogram, and identifies and addresses difficulties or barriers she might have in getting a mammogram. This study will consist of two linked randomized controlled trials. We will recruit 2,120 participants over 12 months from two radiology departments. Three to four months prior to their due date for an annual screening mammogram, these women will receive a reminder letter to schedule a mammogram. In addition, a random sample of them will use TLC-M. All participants in this pre-due intervention study will be evaluated 3 months after their due date to determine whether or not they obtained a mammogram. Of the women who received the letter only in the first trial, those who did not obtain a mammogram during the observation period will enter a past due intervention trial. These women will be randomly assigned to receive a past due reminder letter or to use the TLC-M. Four months later, participants will be evaluated to determine whether they had a mammogram. For both trials mammography rates of those women who used the TLC-M and those who did not will be statistically compared.

Interventions

BEHAVIORALBreast Cancer Screening Compliance

Sponsors

Massachusetts General Hospital
CollaboratorOTHER
Boston Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Masking
SINGLE

Eligibility

Sex/Gender
FEMALE
Age
50 Years to 74 Years
Healthy volunteers
Yes

Inclusion criteria

* Ages 50-74 * A recent (within the last 6 months) negative screening mammogram

Exclusion criteria

* Lack a permanent address or planning to move from the Boston area during the study period * No home telephone or no touch tone service * Cannot use a telephone unassisted * Cannot understand conversational English over the telephone * Major medical illness that would preclude participation * History of breast cancer * Mammography or other breast diagnostic procedures (except CBE) or therapeutic procedures since the last screening mammogram * Another member of household enrolled in the study (to eliminate possible study contamination)

Design outcomes

Primary

MeasureTime frame
Number of women who have repeat screening mammogram

Secondary

MeasureTime frame
Evaluation of intervention for those women who used TLC-M

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026